Colgate-Palmolive Company (CL) JPMorgan 15th Annual U.S. All Stars Conference summary
Event summary combining transcript, slides, and related documents.
JPMorgan 15th Annual U.S. All Stars Conference summary
8 Jul, 2026Innovation and growth strategy
Shifted from line extensions to breakthrough, science-led innovation across all price points, driving both core and premium segments, with whitening and active prevention as key growth drivers.
Leveraged AI and data analytics to accelerate innovation, improve speed to market, and enhance incrementality and performance.
Changed incentives to reward larger, more incremental innovations, especially in pet nutrition, and expanded capacity for new product forms.
Integrated innovation culture with talent development, superior insights, and revenue growth management to support portfolio execution.
Increased advertising spend to support innovation and brand health, particularly in emerging and pet nutrition markets.
Market penetration and regional performance
Focused on driving household penetration, per capita consumption, and value through education programs and targeted commercial strategies.
Revamped flagship oral health education program, integrating it with commercial planning and geo-targeted store execution, resulting in consistent penetration gains.
Achieved significant market share growth in challenging markets like Nigeria by maintaining long-term investment and operational discipline.
Used data analytics and revenue growth management to optimize pricing and portfolio mix, supporting eight consecutive quarters of double-digit growth in Africa-Eurasia.
All divisions posted volume growth, with strong performance in Latin America, Africa-Eurasia, and North America.
Financial performance and outlook
Delivered robust organic sales growth, with 9%+ in the first half and guidance of 6%-8% for the full year, reflecting a shift from pricing-driven to volume-driven growth.
Volume growth outpaced competitors, with 4.7% company-wide and 8.9% in Africa-Eurasia, supported by balanced growth between volume and pricing.
North America saw 5.9% volume growth despite negative pricing, driven by renewed focus on mid-tier products and household penetration.
Managed margin expansion through operational flexibility, disciplined innovation, and increased advertising, even in hyperinflationary and FX-challenged regions.
Shifted focus from percentage margin expansion to growing gross profit dollars, enabling higher advertising investment and sustainable earnings growth.
Latest events from Colgate-Palmolive Company
- Hill’s Pet Nutrition drives growth with innovation, margin recovery, and global expansion focus.CL
Goldman Sachs Global Staples Forum9 Jul 2026 - Strategic innovation, premiumization, and flexible operations drive growth and margin expansion.CL
UBS Global Consumer and Retail Conference8 Jul 2026 - Record sales, margin gains, and robust cash flow position for continued growth in 2025.CL
Q4 20248 Jul 2026 - Transformation, innovation, and global agility drive growth amid regional and market challenges.CL
23rd annual dbAccess Global Consumer Conference3 Jun 2026 - Board elections, 2025 results, and 2030 strategy highlighted; key shareholder proposals rejected.CL
AGM 202614 May 2026 - Net sales up 8.4% to $5.3B, with strong growth in Latin America and EMEA offsetting higher costs.CL
Q1 20261 May 2026 - Director elections, auditor ratification, and key shareholder proposals headline the annual meeting.CL
Proxy filing16 Apr 2026 - Board recommends supporting company proposals, highlights strong governance, and opposes two shareholder proposals.CL
Proxy filing25 Mar 2026 - Board recommends voting for all directors and auditor, against DEI removal and independent chair.CL
Proxy filing25 Mar 2026